<DOC>
	<DOCNO>NCT02977741</DOCNO>
	<brief_summary>Prospective , observational study evaluate effect olanzapine treatment refractory chronic nausea vomiting .</brief_summary>
	<brief_title>Olanzapine Treatment Refractory Chronic Nausea Vomiting</brief_title>
	<detailed_description>Patients identify see Johns Hopkins Gastroenterology Clinic , suffer chronic nausea vomit refractory prokinetic antiemetic medication , prescribed olanzapine treatment nausea vomit . Patients meet criterion enrol gastrointestinal symptom , quality life , psychological symptom assess various questionnaire follow course 3 month .</detailed_description>
	<mesh_term>Nausea</mesh_term>
	<mesh_term>Vomiting</mesh_term>
	<mesh_term>Olanzapine</mesh_term>
	<criteria>1865 year age Able communicate English without aid interpreter Have chronic refractory nausea , meeting follow criterion : 1 . Baseline nausea vomit score VAS 25mm great 2 . Duration symptom least 6 month ( contiguous ) 3 . Intolerance inadequate response prior treatment 1 ) ondansetron another serotonin ( 5HT3 ) antagonist 2 ) metoclopramide domperidone History chemotherapy within last year Current diagnosis cancer Pregnant breastfeeding For female , active effort conceive/become pregnant time study Chronic opioid use ( 3 time week great use ) Alanine aminotransferase ( ALT ) aspartate aminotransferase ( AST ) elevation great 2x upper limit normal ( within 3 month enrollment ) Cirrhosis Unable unwilling stop use metoclopramide use olanzapine Concomitant use antipsychotic ( e.g. , haloperidol ) Prolonged correct QT interval ( QTc ) ( &gt; 470ms men &gt; 480ms woman ) History lifethreatening arrhythmia Hypokalemia ( potassium &lt; 3.1 ) hypomagnesemia ( magnesium &lt; 1.2 ) Metabolic syndrome , define per Adult Treatment Panel III criterion Granulocytopenia ( absolute neutrophil count &lt; 1500 ) History tardive dyskinesia History acute dystonic reaction medication History neuroleptic malignant syndrome</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>January 2017</verification_date>
</DOC>